Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05260268 · ClinicalTrials.gov registry record · NA
Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant
A NA study of Cirrhosis and Medication Adherence, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- NA
- Development phase
- 360
- Enrollment target
- 3
- Study locations
NCT05260268: Recruiting NA study of Cirrhosis and Medication Adherence, sponsored by University of Pennsylvania.
NCT05260268 is a NA study of Cirrhosis and Medication Adherence that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 360 participants, below the 90,402-participant average among 53 other Cirrhosis trials with a reported enrollment target (100% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05260268, a NA study of Cirrhosis and Medication Adherence, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- NA
- Development phase
- 360 participants
- Enrollment target
- 3
- Study locations
Study Summary
Liver transplantation is increasingly performed for older adults with multiple comorbidities. Medication adherence is key to maintaining proper function of the transplanted liver and optimize health; however, adhering to post-transplant treatment is complex. This trial will study how available technology combined with transplant center resources and caregiver support can optimize medication adherence, quality of life, and health outcomes among new liver transplant recipients at 3 centers.
Primary Outcome
Patient self-report of how many pills and how often each medicine was taken over the last 24 hours. Patients will also be asked about the medical indication for each drug. Correct dosing will be measured as a yes/no per drug, having properly shown dose (number of pills), spacing (hours between doses), frequency (times per day), and total pills/day.
Conditions Studied
Interventions
- BEHAVIORAL TEST Intervention
Study Locations (3)
Florida
- University of Miami - Miami
Illinois
- Northwestern University - Chicago
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2022-12-01 |
| Est. Completion | 2027-01-01 |
| Phase | NA |
What NCT05260268 shows while recruiting
NCT05260268 is an interventional study that assigns participants to a tested intervention. The registered 360 participants enrollment target is mid-sized for trials with a published cap, below the 90,402-participant average among 53 other Cirrhosis trials with a reported enrollment target (100% lower).
The record links to 4 conditions, with Cirrhosis appearing as the primary indexed condition, and to 1 intervention - of which TEST Intervention is the first listed.
NCT05260268 reports a single indexed study location in Florida, Illinois, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05260268 about?
NCT05260268 is a clinical study titled "Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant". Liver transplantation is increasingly performed for older adults with multiple comorbidities. Medication adherence is key to maintaining proper function of the transplanted liver and optimize health; however, adhering to post-transplant treatment is complex. This trial will study how available techn...
What is the current status of trial NCT05260268?
This trial is currently recruiting. It is a NA study. The enrollment target is 360 participants. The study started on 2022-12-01. Estimated completion is 2027-01-01.
What conditions does trial NCT05260268 study?
This clinical trial studies the following conditions: Cirrhosis, Medication Adherence, End Stage Liver DIsease, Liver Transplant, Complications.
What interventions are being tested in trial NCT05260268?
The interventions under investigation include: TEST Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05260268?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05260268 being conducted?
This trial has 3 study locations across Florida, Illinois, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cirrhosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05260268's enrollment target sits among peer trials
360 9th of 53 higher than 45 of 53 other Cirrhosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cirrhosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
LiverSleep: A Behavioral Sleep Intervention for Patients With Cirrhosis and Insomnia
RECRUITING · NA
-
Copper Supplementation in Cirrhosis
RECRUITING · NA
-
HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
RECRUITING · NA
-
CirrhosisRx CDS System
RECRUITING · NA
-
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
RECRUITING · NA
-
Microbiome Modulation With Prebiotics in PTSD and Cirrhosis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747836 · 360 participants
Ultrasound Analysis of Human Carpal Tunnel System
- NCT04089046 · 360 participants · NA
Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)
- NCT04130503 · 360 participants · NA
The Recovery in Stroke Using PAP Study
- NCT04160000 · 360 participants · Phase 4
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI